MDM2 and ameloblastoma: The main finding of the present study is that ameloblastomas overexpressing MDM2 did not show MDM2 amplification, as accessed by FISH, whereas some of them expressed BRAFV600E in the presence of WTp53, as was shown by immunohistochemistry.